We are the global leader in the therapeutic application of marine-derived enzymes. Our technology of developing and manufacturing formulations containing marine-derived enzymes is called Penzyme® technology and is at the core of our intellectual property. Our use of cod enzymes (that we call Penzyme®) for therapeutic application is protected by a global patent. Our core and clinical research has demonstrated effectiveness of Penzyme® against a variety of skin conditions, wound healing and viral and bacterial infections (Gudmundsdóttir A., Hilmarsson H., Stefansson B. (2013).
| Website | http://zymetech.com |
| Revenue | $7 million |
| Employees | View employees |
| Founded | 1999 |
| Address | Fiskislóð 39, Reykjavík 101, IS |
| Phone | +354 551 5400 |
| Industry | Pharmaceuticals, Biotechnology, Clinical Trials, Health Care, Other Pharmaceuticals and Biotechnology, Healthcare, Manufacturing, Therapeutics |
| Competitors | Stellartech Research Corporation, Tex Biosciences (P) Ltd, Specialty Enzymes & Probiotics, Tracoe Medical GmbH, Atc Technologies Inc, Biometrix, Bacchus Vascular (view competitors) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Zymetech employee's phone or email?
Zymetech Questions
The Zymetech annual revenue was $7 million in 2026.
The NAICS codes for Zymetech are [3254, 32, 325].
The SIC codes for Zymetech are [283, 28].
